Colleen A Ramsower
Overview
Explore the profile of Colleen A Ramsower including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gutmair K, Villa D, Cunningham N, Silkenstedt E, Rimsza L, Ramsower C, et al.
Blood Adv
. 2025 Feb;
PMID: 39983085
No abstract available.
2.
Ramsower C, Rosenthal A, Robetorye R, Mwangi R, Maurer M, Villa D, et al.
Br J Haematol
. 2023 Oct;
204(1):160-170.
PMID: 37881141
Mantle cell lymphoma (MCL) is clinically and biologically heterogeneous. While various prognostic features have been proposed, none currently impact therapy selection, particularly in older patients, for whom treatment is primarily...
3.
Gibson S, Dojcinov S, Dotlic S, Hartmann S, Hsi E, Klimkowska M, et al.
Virchows Arch
. 2023 Oct;
484(5):877.
PMID: 37828241
No abstract available.
4.
Gibson S, Dojcinov S, Dotlic S, Hartmann S, Hsi E, Klimkowska M, et al.
Virchows Arch
. 2023 Aug;
483(6):733-749.
PMID: 37530791
Session 3 of the 2021 European Association for Haematopathology/Society for Hematopathology Workshop focused on mediastinal large B cell lymphomas and surrounding gray areas. One half of the session was dedicated...
5.
Loveday T, Duns G, Rimsza L, Rech K, Cook J, Robetorye R, et al.
Blood Adv
. 2022 Oct;
7(6):893-899.
PMID: 36240289
We investigated the clinicopathologic features of 5 follicular lymphomas (FLs) that transformed (tFL) morphologically to diffuse large B-cell lymphomas (DLBCLs) and had a primary mediastinal large B-cell lymphoma (PMBL)-like gene...
6.
Zhu Y, Bruins L, Chen X, Shi C, de Campos C, Meurice N, et al.
EJHaem
. 2022 Sep;
3(3):804-814.
PMID: 36051067
Identifying biomarkers associated with disease progression and drug resistance are important for personalized care. We investigated the expression of 121 curated genes, related to immunomodulatory drugs (IMiDs) and proteasome inhibitors...
7.
Villa D, Hoster E, Hermine O, Klapper W, Szymczyk M, Bosly A, et al.
Blood Adv
. 2022 Apr;
6(18):5285-5294.
PMID: 35439293
The objective of this study was to explore differences in outcomes between first-line rituximab plus bendamustine (R-B) and R-CHOP/R-DHAP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone, dexamethasone, cytarabine, cisplatin) in transplant-eligible patients...
8.
Robetorye R, Ramsower C, Rosenthal A, Yip T, Wendel Spiczka A, Glinsmann-Gibson B, et al.
J Hematop
. 2021 Aug;
12(1):3-10.
PMID: 34447482
Diffuse large B-cell lymphomas (DLBCL) represent a clinically heterogeneous group of lymphomas that are classified together based on similarities in morphology and immunophenotype. Gene expression profiling further classifies DLBCL into...
9.
Ramsower C, Maguire A, Robetorye R, Feldman A, Syrbu S, Rosenthal A, et al.
J Hematop
. 2020 Nov;
13(4):231-238.
PMID: 33193905
Mantle cell lymphoma (MCL) is a clinically heterogeneous B cell malignancy for which a variety of prognostic factors have been proposed. Previously, a digital gene expression profiling "proliferation signature" capable...
10.
Chatzopoulos K, Sotiriou S, Collins A, Kartsidis P, Schmitt A, Chen X, et al.
Head Neck Pathol
. 2020 Oct;
15(2):509-522.
PMID: 33010009
The tumor immune microenvironment of oral tongue squamous cell carcinoma may be accountable for differences in clinical behavior, particularly between different age groups. We performed RNA expression profiling and evaluated...